Assessment of Predictive Values of Tumor Markers
Reviewing the literature, it would appear that tumor markers have often flattere
Reviewing the literature, it would appear that tumor markers have often flattered to deceive. Early promise does not often seem to be borne out in extended trials. Despite apparently high specificity, very few markers are capable of assisting in a screening process.
- 上一篇
Liposomal Doxorubicin and nab-Paclitaxel: Nanoparticle Cancer Chemotherapy in Current Clinical Use
Liposomal doxorubicin and nab -paclitaxel are nanoparticle f...
- 下一篇
Gene Expression Profiling in Cervical Cancer: Identification of Novel Markers for Disease Diagnosis
Cervical cancer, a potentially preventable disease, remains ...